Update in Cardiology
Authors: Peter H. Stone
Journal: Annals of Internal Medicine (2003)

Updates from the Annual Session18 March 2003Update in CardiologyPeter H. Stone, MDPeter H. Stone, MDFrom Brigham and Women's Hospital, Boston, Massachusetts.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-138-6-200303180-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail This Update looks back at a most exciting year in cardiology and anticipates novel therapeutic approaches. Topics discussed are unstable coronary artery disease; treatments of chronic coronary artery disease; risk factors for atherosclerotic cardiovascular disease, notably C-reactive protein; management of heart failure; and a potpourri of cardiovascular issues, including valvular disease, peripheral vascular disease, and arrhythmia.Unstable Coronary Artery SyndromesRoughly 1.5 million hospital admissions each year in the United States result from unstable angina or nonST-segment elevation myocardial infarction. A reliable way of stratifying risk among these patients would permit those more likely to develop adverse cardiac events to ...References1. Solomon DH, Stone PH, Glynn RJ, Ganz DA, Gibson CM, Tracy R, et al. . Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol. 2001;38:969-76. [PMID: 11583866] CrossrefMedlineGoogle Scholar2. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet. 2001;357:1905-14. [PMID: 11425410] CrossrefMedlineGoogle Scholar3. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-13. [PMID: 9718051] CrossrefMedlineGoogle Scholar4. Alexander KP, Newby LK, Hellkamp AS, Harrington RA, Peterson ED, Kopecky S, et al. . Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol. 2001;38:1-7. [PMID: 11451256] CrossrefMedlineGoogle Scholar5. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, et al. . Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:499-503. [PMID: 11468217] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Peter H. Stone, MDAffiliations: From Brigham and Women's Hospital, Boston, Massachusetts.Corresponding Author: Peter H. Stone, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115; e-mail, phstone@bics.bwh.harvard.edu. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 18 March 2003Volume 138, Issue 6 Page: 482-487 Keywords C-reactive proteins Heart failure Implantable cardioverter defibrillators Myocardial infarction Stable coronary artery disease Statins Stenosis Stent implantation Stroke Unstable angina ePublished: 18 March 2003 Issue Published: 18 March 2003 Copyright & PermissionsCopyright © 2003 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...